164 related articles for article (PubMed ID: 16045698)
1. Prolonged dermatitis distant to the site of squaric acid dibutyl ester applications and recovery of alopecia areata.
Ujiie H; Sawamura D; Shibaki A; Shimizu H
Clin Exp Dermatol; 2005 Sep; 30(5):579-80. PubMed ID: 16045698
[No Abstract] [Full Text] [Related]
2. [Squaric acid dibutyl ester in the treatment of severe alopecia areata].
Miranda A; Mato F; Quiñones PA
Med Cutan Ibero Lat Am; 1984; 12(3):273-8. PubMed ID: 6384701
[TBL] [Abstract][Full Text] [Related]
3. [Topical therapy of alopecia areata with squaric acid dibutyl ester].
Morishita M; Nagai T; Sato Y
Nihon Hifuka Gakkai Zasshi; 1987 Jan; 97(1):61-4. PubMed ID: 3573366
[No Abstract] [Full Text] [Related]
4. Questions raised by skin reactions observed during squaric acid dibutyl ester contact sensitization.
Stinco G; Patrone P
Contact Dermatitis; 2000 Jul; 43(1):52-3. PubMed ID: 10902598
[No Abstract] [Full Text] [Related]
5. Efficacy and safety of the topical sensitizer squaric acid dibutyl ester in Alopecia areata and factors influencing the outcome.
Ajith C; Gupta S; Kanwar AJ
J Drugs Dermatol; 2006 Mar; 5(3):262-6. PubMed ID: 16573260
[TBL] [Abstract][Full Text] [Related]
6. Iatrogenic cutaneous lymphoid hyperplasia induced by squaric acid dibutyl ester.
Takahagi S; Numata T; Tanaka A; Hide M
Contact Dermatitis; 2021 Jul; 85(1):88-90. PubMed ID: 33438236
[No Abstract] [Full Text] [Related]
7. Clinical experience on the treatment of alopecia areata with squaric acid dibutyl ester.
Giannetti A; Orecchia G
Dermatologica; 1983; 167(5):280-2. PubMed ID: 6653853
[TBL] [Abstract][Full Text] [Related]
8. Discoid lupus erythematosus exacerbated by contact dermatitis caused by use of squaric acid dibutylester for topical immunotherapy in a patient with alopecia areata.
Shimaoka Y; Hatamochi A; Hamasaki Y; Suzuki H; Ikeda H; Yamazaki S
J Dermatol; 2008 Mar; 35(3):151-3. PubMed ID: 18346258
[TBL] [Abstract][Full Text] [Related]
9. Lentiginous eruption due to topical immunotherapy.
Tosti A; Piraccini BM; Misciali C; Vincenzi C
Arch Dermatol; 2003 Apr; 139(4):544-5. PubMed ID: 12707112
[No Abstract] [Full Text] [Related]
10. Transient leucoderma appearing in an untreated area following contact immunotherapy for alopecia areata.
Nasca MR; Micali G; Pulvirenti N; Licastro Cicero R
Eur J Dermatol; 1998 Mar; 8(2):125-6. PubMed ID: 9649675
[TBL] [Abstract][Full Text] [Related]
11. [In situ lymphocyte subpopulation in alopecia areata after treatment with squaric acid dibutyl ester].
Rosso R; Paulli M; Marelli MA; Douville H; Orecchia G
G Ital Dermatol Venereol; 1988 Nov; 123(11):575-7. PubMed ID: 3254332
[No Abstract] [Full Text] [Related]
12. Squaric acid dibutyl ester in the treatment of alopecia areata.
Barth JH; Darley CR; Gibson JR
Dermatologica; 1985; 170(1):40-2. PubMed ID: 3882480
[TBL] [Abstract][Full Text] [Related]
13. [Pigmentation abnormalities in the course of topical immunotherapy of alopecia areata].
Valsecchi R; Pansera B; Rossi A; Cainelli T
G Ital Dermatol Venereol; 1989; 124(1-2):31-2. PubMed ID: 2527809
[TBL] [Abstract][Full Text] [Related]
14. Side-effects during treatment with SADBE.
Frattasio A; Germino M; Cargnello S; Patrone P
Contact Dermatitis; 1997 Feb; 36(2):118-9. PubMed ID: 9062760
[No Abstract] [Full Text] [Related]
15. Childhood epidermolysis bullosa acquisita during squaric acid dibutyl ester immunotherapy for alopecia areata.
Guerra L; Pacifico V; Calabresi V; De Luca N; Castiglia D; Angelo C; Zambruno G; Di Zenzo G
Br J Dermatol; 2017 Feb; 176(2):491-494. PubMed ID: 27208509
[TBL] [Abstract][Full Text] [Related]
16. Nickel sensitivity as a complication of squaric acid dibutylester treatment of alopecia areata.
Valsecchi R; Cainelli T
Contact Dermatitis; 1985 Apr; 12(4):234. PubMed ID: 4017578
[No Abstract] [Full Text] [Related]
17. Efficacy of topical sensitizers in the treatment of alopecia areata.
Rokhsar CK; Shupack JL; Vafai JJ; Washenik K
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):751-61. PubMed ID: 9810892
[TBL] [Abstract][Full Text] [Related]
18. Persistent allergic contact dermatitis at the site of primary sensitization with squaric acid dibutyl ester.
Nasca MR; Cicero RL; Innocenzi D; Micali G
Contact Dermatitis; 1995 Dec; 33(6):438. PubMed ID: 8706413
[No Abstract] [Full Text] [Related]
19. Squaric acid dibutylester: indications for use and efficacy in alopecia areata.
Pardasani AG; Turner E; McMichael AJ
Arch Dermatol; 2001 Jul; 137(7):970-2. PubMed ID: 11453831
[No Abstract] [Full Text] [Related]
20. Treatment of alopecia areata with squaric acid dibutylester.
Hill ND; Bunata K; Hebert AA
Clin Dermatol; 2015; 33(3):300-4. PubMed ID: 25889130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
